Insider · CIK 0001780085

Nash Huw M.

Reports to the SEC for 1 company · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001780085

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-02	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,467 sh	$13.10	−$32.3K	33
2024-07-02	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−33 sh	$13.90	−$458.7	0
2024-05-20	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+50K sh	$0.40	+$20K	50,000
2024-05-20	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−50K sh	$15.39	−$770K	0
2024-05-20	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−50K sh	—	—	46,000
2024-04-01	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+50K sh	$0.40	+$20K	61,329
2024-04-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−60.9K sh	$13.22	−$806K	400
2024-04-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−400 sh	$13.61	−$5,444	0
2024-04-01	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−50K sh	—	—	96,000
2024-03-27	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+60K sh	—	—	60,000
2024-03-27	STOKStoke Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Business Officer	AAward	+40K sh	—	—	40,000
2024-03-19	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−4,116 sh	$6.10	−$25.1K	11,329
2024-03-15	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+13.1K sh	—	—	15,445
2024-03-15	STOKStoke Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−13.1K sh	—	—	39,300
2023-12-01	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−65.6K sh	—	—	0
2023-12-01	STOKStoke Therapeutics, Inc. · Restricted Stock Unit (RSU)A Award	Chief Business Officer	AAward	+8,463 sh	—	—	8,463
2023-03-15	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+78.6K sh	—	—	78,600
2023-03-15	STOKStoke Therapeutics, Inc. · Restricted Stock Unit (RSU)A Award	Chief Business Officer	AAward	+52.4K sh	—	—	52,400
2022-12-07	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+62K sh	—	—	62,000
2022-03-15	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+107K sh	—	—	107,400
2022-01-03	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+3,800 sh	$2.19	+$8,322	3,800
2022-01-03	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−1,497 sh	$22.47	−$33.6K	2,303
2022-01-03	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,103 sh	$23.40	−$49.2K	200
2022-01-03	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−200 sh	$24.07	−$4,814	0
2022-01-03	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−3,800 sh	—	—	86,822
2021-12-01	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,700 sh	$2.19	+$12.5K	5,700
2021-12-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−3,200 sh	$23.96	−$76.7K	2,500
2021-12-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,500 sh	$25.06	−$62.7K	0
2021-12-01	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,700 sh	—	—	90,622
2021-11-03	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+1,900 sh	$2.19	+$4,161	1,900
2021-11-03	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−1,900 sh	$25.00	−$47.5K	0
2021-11-03	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−1,900 sh	—	—	96,322
2021-11-01	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+3,800 sh	$2.19	+$8,322	3,800
2021-11-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,190 sh	$23.41	−$51.3K	1,610
2021-11-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−1,610 sh	$23.72	−$38.2K	0
2021-11-01	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−3,800 sh	—	—	98,222
2021-10-01	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,700 sh	$2.19	+$12.5K	5,700
2021-10-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−5,700 sh	$24.83	−$142K	0
2021-10-01	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,700 sh	—	—	102,022
2021-09-01	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,700 sh	$2.19	+$12.5K	5,700
2021-09-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−5,700 sh	$26.00	−$148K	0
2021-09-01	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,700 sh	—	—	107,722
2021-08-02	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,700 sh	$2.19	+$12.5K	5,700
2021-08-02	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−5,700 sh	$28.87	−$165K	0
2021-08-02	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,700 sh	—	—	113,422
2021-07-01	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,700 sh	$2.19	+$12.5K	5,700
2021-07-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−5,700 sh	$33.33	−$190K	0
2021-07-01	STOKStoke Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,700 sh	—	—	119,122
2021-06-01	STOKStoke Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−575 sh	$39.43	−$22.7K	0
2021-06-01	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+575 sh	$2.19	+$1,259.25	575

Recent filings

Accepted (ET)
Jul 34
Nash Huw M.0001415889-24-019169
SEC(opens sec.gov)
Jun 74
Nash Huw M.0001415889-24-016008
SEC(opens sec.gov)
May 224
Nash Huw M.0001415889-24-014093
SEC(opens sec.gov)
Apr 34
Nash Huw M.0001415889-24-009993
SEC(opens sec.gov)
Mar 194
Nash Huw M.0001415889-24-008686
SEC(opens sec.gov)
Dec 54
Nash Huw M.0001209191-23-057403
SEC(opens sec.gov)
Mar 174
Nash Huw M.0001209191-23-019656
SEC(opens sec.gov)
Dec 94
Nash Huw M.0001209191-22-060546
SEC(opens sec.gov)
Mar 174
Nash Huw M.0001209191-22-019684
SEC(opens sec.gov)

Companies

Stoke Therapeutics, Inc.Chief Business OfficerSTOK

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730